FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileApotex Health Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
APTX.TO
Apotex Health Corp. Stock AnalysisComprehensive stock analysis for Apotex Health Corp. (APTX.TO) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAPTX.TO
APTX.TO
Apotex Health Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
APTX.TO
  1. Home
  2. Stocks
  3. Apotex Health Corp.

Apotex Health Corp.

🇨🇦APTX.TO•TSX

Apotex Health Corp.

🇨🇦APTX.TO•TSX
Market cap
$9.41B
P/E ratio
25.47

Your view on APTX.TO

Mkt Cap
$9.41B
P/E
25.47
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Apotex Health Corp.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Jeff Watson
Headquarters
150 Signet Drive, Toronto, ON, CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Jeff Watson
Headquarters
150 Signet Drive, Toronto, ON, CA
Description

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.

The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products.

It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars.

The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Apotex Health Corp.. Starting points for Apotex Health Corp.: P/E 25.5, EPS C$1.61, beta -0.71 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Apotex Health Corp.. Apotex Health Corp. paid C$0.06 per share over the last year — a 0.1% yield at the current C$41.17 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Apotex Health Corp.. Trailing twelve-month EPS for Apotex Health Corp. stands at C$1.61. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis yearYear to Mar 2027Next yearYear to Mar 2028
Average estimateCAD 1.96CAD 2.38
Lowest estimateCAD 1.87CAD 2.20
Highest estimateCAD 2.07CAD 2.63
Number of analysts77
A year agoCAD 1.61—
Growth vs a year ago+21.5%—

Revenue estimates

TotalThis yearYear to Mar 2027Next yearYear to Mar 2028
Average estimateCAD 3.44BCAD 3.72B
Lowest estimateCAD 3.39BCAD 3.60B
Highest estimateCAD 3.45BCAD 3.77B
Number of analysts1414
A year agoCAD 3.49B—
Growth vs a year ago−1.5%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Apotex Health Corp.. Apotex Health Corp. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold APTX.TO14 companies · 7 funds
Compare APTX.TO with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
GUD.TOKnight Therapeutics Inc.HealthcareDrug Manufacturers - Specialty & Generic$1.1B
LLY.TOEli Lilly and CompanyHealthcareDrug Manufacturers - General$1.7T
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
LMLLFPharmadrug Inc.HealthcareOTC$746,817
LNTHLantheus Holdings, Inc.HealthcareNASDAQ$6.7B
LOVE.TOCannara Biotech Inc.HealthcareTSX$198.1M
LOVFFCannara Biotech Inc.HealthcareOTC$125.5M
LOWLFLowell Farms Inc.HealthcareOTC$1,815
LTHOLegacy Technology Holdings, Inc.HealthcareOTC$1,720
LUFFFHerbal Dispatch Inc.HealthcareOTC$17.1M
LVRLFCordovaCann Corp.HealthcareOTC$3.3M
LVVVLiveWire Ergogenics, Inc.HealthcareOTC$1.6M
LVZPFLivzon Pharmaceutical Group Inc.HealthcareOTC$6.1B
LYPHFLuye Pharma Group Ltd.HealthcareOTC$1.5B
MAJIMarijuana Inc.HealthcareOTC$1.8M
ETFs holding Apotex Health Corp.
TickerFundFund assets% of the fund
TGED.TOTD Active Global Enhanced Dividend ETF$1.6B in assets1.83%
FBCGFidelity Blue Chip Growth ETF$7.3B in assets0.08%
TTP.TOTD Canadian Equity Index ETF$6.8B in assets0.08%
QCN.TOMackenzie Canadian Equity Index ETF$6.4B in assets0.08%
MCSM.TOManulife Multifactor Canadian SMID Cap Index ETF$334M in assets0.62%
DANC.TODesjardins Market Neutral ETF$201M in assets0.62%
ISCFiShares International Small-Cap Equity Factor ETF$717M in assets0.06%

Largest holders first, then the funds most concentrated in APTX.TO.

Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Apotex Health Corp.

APTX.TO AnalysisFair
Past
5
Growth
3
Health
1
Profit
0
Value
1